FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically to pharmaceutical industry, producing preparations of therapeutic and preventive purposes, and represents pharmaceutical composition of active substances for external application, performed as soft dosage form. Bifunctional therapeutic agent is disclosed containing biologically active substances as chondroitin sulphate, celecoxib, dimethyl sulphoxide, and ointment base - the rest, in certain proportions.
EFFECT: agent provides creation of appliable transdermal preparation in form of gel for long-term local application, which exhibits reparative, anti-inflammatory, and analgesic activities, and can be used as independent or auxiliary therapeutic agent in conditions associated with reduction of locomotor apparatus functions.
3 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FORLOCOMOTOR DISORDERS TREATMENT | 2016 |
|
RU2630064C1 |
| AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
| EXTERNAL PREPARATION FOR TREATING ARTHROPATHIES AND SOFT TISSUE CONDITIONS | 2007 |
|
RU2377974C2 |
| AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2259204C1 |
| TRANSDERMAL PREPARATION FOR TREATMENT AND PREVENTION OF DISEASES OF JOINTS AND SOFT TISSUES | 2018 |
|
RU2685436C1 |
| METHOD FOR PRODUCING BIOLOGICALLY ACTIVE PHARMACEUTICAL SUBSTANCE FOR FEEDING EXTRACELLULAR MATRIX AND PREVENTING LOCOMOTOR DISEASES AND BARRIER FUNCTIONS OF RESPIRATORY AND DIGESTIVE ORGANS | 2019 |
|
RU2730477C1 |
| MEDICINAL COMPOSITION FOR TREATING JOINT DISEASES (VERSIONS) | 2009 |
|
RU2408380C1 |
| TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
| AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271811C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
